Details

Autor(en) / Beteiligte

• Barragán-Reyes, Armando
• Jácome, Luis Esaú López
• Perales-Martínez, Diana
• Nava-Ruiz, Alejandra
• Hernández, María de Lourdes García
• Cornejo-Juárez, Patricia
• Rincón-Zuno, Joaquín
• Camacho, Adrián
• Cendejas, Rafael Franco
• Guzmán, José M Feliciano
• Rivera-Martínez, Norma E
• Ontañón-Zurita, Diego
• Reséndiz-Sánchez, Jesús
• Juárez-Hernández, Eva
• Aguilar-Zapata, Daniel

Titel

Fusariosis in Mexico: A 10-year retrospective series

Ist Teil von

• Medical mycology (Oxford), 2023-12, Vol.61 (12)

Ort / Verlag

Oxford University Press

Erscheinungsjahr

2023

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Fusarium species represent an opportunistic fungal pathogen. The data in Mexico about Fusarium infections in humans are scarce. Here, we present a retrospective series of patients with a confirmed diagnosis of fusariosis in eight different hospitals in Mexico from January 2010 to December 2019. The diagnosis of proven fusariosis was made according to the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (EORT/MSG) criteria. A total of 49 cases were identified in our series. Most patients had burn injuries (49%), and 37% had hematological malignancies. Most patients had fire injuries (40%), followed by electric injuries (8%), febrile neutropenia (10%), and pancytopenia (6%). Patients had skin and soft tissue involvement in 49%, followed by blood culture isolation and biopsies from different sites of the body (lung, sinuses, bone tissue, and eyes). Febrile neutropenia (10%) and fungemia (8%) were the most common clinical syndromes in immunosuppressed patients. Most patients received monotherapy (67%), where voriconazole was used in 30% of the cases, followed by conventional amphotericin B (16%), and lipidic formulations of amphotericin B in 10% (either liposomal amphotericin B or amphotericin B lipid complex). Combination therapy was used in 20% of the cases, and the most common combination therapy was triazole plus any lipidic formulation of amphotericin B (10%). Mortality related to Fusarium infection occurred in 22% of patients. Fusariosis is a serious threat. Burn injuries and hematologic malignancies represent the most common causes of infection in this small series from Mexico. Lay Summary This study describes the epidemiological characteristics of patients with fusariosis from a multicenter cohort in Mexico. These findings provide information from this invasive fungal disease that threatens different countries in Latin America.